India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India's pharmaceutical exports are set to reach USD 65 billion by 2030 and USD 350 billion by 2047, placing India among the ...

India’s CDMO market has seen a record growth trajectory due to cost advantages, technological advancements, and strong ...

India's pharmaceutical exports are projected to reach USD 65 billion by 2030, with a target of USD 350 billion by 2047, ...

The three-day conference will address crucial topics related to pharmaceutical regulation, impurity assessment, ...

While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

CN Water is a leading water treatment solution provider with over 150 clients across industries and 700 operational plants ...

India’s contract research (CRO), development and manufacturing (CDMO) services markets doubled between 2019 and 2023 ...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...

OliX Pharmaceuticals, a gene therapy developer, recorded a daily limit up on the 10th after news that it signed a global ...

One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...